TrialEuropean heart journal2015
ODYSSEY FH I and FH II: 78 week results with alirocumab treatment in 735 patients with heterozygous familial hypercholesterolaemia.
John J P Kastelein et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
218 papers cite itlatest 60 shown
this paperpooled ittrialcites it